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Metazoan cell cycle-regulated histone mRNAs are unique cellular mRNAs in that they terminate in a highly
conserved stem-loop structure instead of a poly(A) tail. Not only is the stem-loop structure necessary for 3-end
formation but it regulates the stability and translational efficiency of histone mRNAs. The histone stem-loop
structure is recognized by the stem-loop-binding protein (SLBP), which is required for the regulation of mRNA
processing and turnover. In this study, we show that SLBP is required for the translation of mRNAs containing
the histone stem-loop structure. Moreover, we show that the translation of mRNAs ending in the histone
stem-loop is stimulated in Saccharomyces cerevisiae cells expressing mammalian SLBP. The translational
function of SLBP genetically required eukaryotic initiation factor 4E (eIF4E), eIF4G, and eIF3, and expressed
SLBP coisolated with S. cerevisiae initiation factor complexes that bound the 5 cap in a manner dependent on
eIF4G and eIF3. Furthermore, eIF4G coimmunoprecipitated with endogenous SLBP in mammalian cell
extracts and recombinant SLBP and eIF4G coisolated. These data indicate that SLBP stimulates the trans-
lation of histone mRNAs through a functional interaction with both the mRNA stem-loop and the 5 cap that
is mediated by eIF4G and eIF3.
Most cellular mRNAs terminate in a poly(A) tail to which
the poly(A)-binding protein (PABP) binds. PABP is required
for translation initiation through its interaction with eukaryotic
initiation factor 4G (eIF4G) and eIF4B (7, 30, 32, 33, 44, 55),
and this interaction results in an increase in the affinity of
PABP for poly(A) RNA and an increase in the affinity of
eIF4F for the 5 cap (m7GpppN, where N represents any
nucleotide) (32, 33, 59). Those mRNAs that naturally lack a
poly(A) tail present an apparent paradox in that, in the ab-
sence of the poly(A) tail, the cap should be virtually nonfunc-
tional, and consequently, the mRNA should be rendered trans-
lationally incompetent. Expression of the cell cycle-regulated
histone mRNAs is tightly coupled to nuclear DNA synthesis
during the S phase of the cell cycle (6), which is achieved
through the regulation of their transcription, processing, and
mRNA stability (21, 25, 51). Changes in transcription and
3-end processing account, in part, for the regulation of histone
expression mRNA during the G1 phase, whereas the mRNA is
specifically destabilized during the G2 phase (24). Cell cycle-
regulated histone mRNAs represent the only known class of
cellular mRNAs that do not terminate in a poly(A) tail but
instead contain a 3-terminal stem-loop structure that is highly
conserved among metazoans (26, 36). A 31-kDa stem-loop-
binding protein (SLBP) that is associated with polysomes and
specifically binds to the histone stem-loop structure has been
identified (23, 35, 43, 58). The requirements for histone
mRNA 3-end processing include the stem-loop and SLBP (13,
14, 57) and a downstream purine-rich region that forms a
duplex with a complementary sequence at the 5 end of U7
snRNA (5, 9, 12, 38, 52). SLBP binds to the histone 3-terminal
stem-loop in the nucleus, remains bound to the mRNA as it is
exported to the cytoplasm, and is necessary for the cell cycle
regulation of mRNA stability and localization of the mRNA to
polysomes (13, 23, 34, 41, 53).
Previous work has demonstrated that the histone stem-loop
was necessary and sufficient to support the translation of re-
porter mRNAs in animal cells when present at the 3 terminus
and, like a poly(A) tail, was functionally dependent on the cap
(17). Although SLBP is necessary to mediate the other regu-
latory aspects associated with the histone stem-loop, its role in
translation initiation has not been demonstrated. Moreover,
how SLBP might promote efficient translation initiation is un-
known.
In this study, we show that SLBP is required for the trans-
lation of mRNAs terminating in the histone stem-loop. The
stimulatory effect of SLBP can be recapitulated in Saccharo-
myces cerevisiae cells expressing mammalian SLBP. Genetic
analysis indicated that the translational function of SLBP re-
quires eIF4E, eIF4G, and eIF3. SLBP copurified with these
initiation factors when they were isolated through their binding
either to the 5 cap or to poly(A)-Sepharose. Coisolation stud-
ies of SLBP with cap- or poly(A)-associated initiation factor
complexes indicated that the association of SLBP with eIF4F
required eIF4G and eIF3. Moreover, eIF4G and SLBP coim-
munoprecipitate from mammalian cell extract and copurify as
recombinant proteins. These data indicate that SLBP is func-
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tionally similar to PABP in that it stimulates the translation of
histone mRNAs through an interaction with the 5 terminus of
the mRNA that is mediated by cap-associated initiation fac-
tors.
MATERIALS AND METHODS
mRNA constructs, electroporation, and luciferase assays. The pT7-luc con-
struct, in which the firefly luciferase coding region is under the control of the T7
promoter, has been described previously (16). The histone and related sequences
were introduced from synthetic oligonucleotides into the BamHI and KpnI sites
of the pT7-luc construct. Specifically, a 32-bp fragment containing the consensus
histone stem-loop sequence was introduced 27 bases downstream of the stop
codon (similar to the spacing present in histone mRNAs) of the luc reporter gene
in a T7-based vector. A restriction site (AflII) incorporated into the construct
immediately downstream of the stem-loop (luc-SLWT) allowed the in vitro pro-
duction of capped luc mRNA terminating in the histone stem-loop. In vitro
transcription was carried out as described previously (17). The total length of the
3 untranslated region was 49 bases. The same luc mRNA construct with the
consensus histone stem-loop sequence reversed (luc-SLR) served as the negative
control. Yeast electroporation and luciferase assays were performed essentially
as described previously (15, 17). For rapamycin treatment, cells were treated for
3 h prior to spheroplasting, during recovery, and during post-RNA delivery.
Amino acid starvation was imposed by growing cells in SD medium containing 10
mM 3-aminotriazole for 2 h prior to spheroplasting, during recovery, and during
post-RNA delivery.
Functional mRNA half-life analysis. The rate of luciferase protein production
was used as a measure of translational efficiency, and the length of time over
which luciferase protein continued to accumulate was used to calculate message
stability. Following the delivery of each mRNA construct by electroporation,
aliquots of cells were removed at time intervals and luciferase assays were
performed. The kinetics of luc mRNA translation were determined by following
the appearance of protein as measured by enzyme activity plotted as a function
of time. Once loaded onto polysomes, translation proceeds at a rate (i.e., the
slope of each curve) that is dictated by its translational efficiency and for a period
of time that is determined by the stability of the mRNA. The eventual degrada-
tion of the mRNA results in a decreased rate of protein accumulation. Following
degradation of the mRNA, further accumulation of luciferase protein ceases,
represented by the plateau of each curve. Those forms of an mRNA that are
more stable will be translationally active longer, represented in a kinetic analysis
by a longer period of time over which the protein will continue to accumulate.
The functional half-life is defined as the amount of time needed to complete a
50% decay in the capacity of an mRNA to synthesize protein.
m7GTP-Sepharose 4B and poly(A)-agarose purification. eIF4F from yeast and
mammalian cells was purified with m7GTP-Sepharose as previously described
(47). For yeast, the crude extract was made from spheroplasts (from 250 ml of
cell culture) in 2.5 ml of buffer M (20 mM Tris [pH 7.5], 0.2 mM EDTA, 100 mM
KCl, 5 mM MgCl2, 5% glycerol, 5 mM -mercaptoethanol, and 1 mM dithio-
threitol [DTT] with protease and phosphatase inhibitors). Mammalian 293 cells
in buffer M were sonicated for 1 min, the cell debris was pelleted, and the
supernatant was used for binding to m7GTP-Sepharose 4B. The m7GTP-Sepha-
rose resin was washed three times with buffer M. Two hundred microliters of
resin was used per 250 ml of yeast culture, and 100 l of resin was used for two
100-mm-diameter plates of 293 cells. Binding was carried out at 4°C for 30 min
with gentle shaking. The resin was collected, the supernatant was saved as the
flowthrough, and the resin was washed three to five times with buffer M and
eluted with 100 M m7GTP.
For poly(A)-agarose purification, cell extract was prepared as described above,
except that buffer PA [10 mM HEPES (pH 7.6), 100 mM potassium acetate, 1
mM CaCl2, 1 mM magnesium acetate, 5% glycerol, 1 mM DTT, and protease
inhibitors] was used. Purification was carried out as previously described (32).
After batch binding for 30 min at 4°C, the resin was collected and washed three
times with buffer PA and protein was recovered in sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis sample buffer.
Purification of His-tagged SLBP by metal affinity chromatography. Co2 resin
(Clontech) was used as described in the manufacturer’s protocol. Cells were
disrupted in binding buffer (50 mM sodium phosphate [pH 7.0], 300 mM NaCl)
with sonication. Extract was bound to resin at 4°C for 30 min and washed three
times with binding buffer (with 5 mM imidazole), and bound protein was eluted
with 150 mM imidazole.
Western analysis. Anti-eIF4E and anti-PABP antisera were raised against
recombinant protein. A human anti-eIF4A antibody was used to detect the yeast
homolog. Anti-SLBP antibody was raised against the C-terminal 13-amino-acid
region as described previously (58). Following resolution by SDS-polyacrylamide
gel electrophoresis, protein was transferred to a nitrocellulose membrane which
was blocked in 5% dry milk–phosphate-buffered saline containing 0.1% Tween
20 (PBST) for 2 h. The membrane was incubated with the primary antibody
(used at dilutions of 1:1,000 to 1:2,000) for 1 to 2 h at room temperature, washed
three times with PBST, incubated with secondary antibody (immunoglobulin
G-horseradish peroxidase) for 1 h at room temperature, and washed three times
with PBST, and the signal was revealed by an enhanced chemiluminescence
reaction. Membranes were reprobed following stripping by incubating the mem-
brane in buffer D (2% SDS, 62.5 mM Tris [pH 6.8], 100 mM -mercaptoethanol)
for 15 min at 60°C with shaking.
Immunoprecipitation. Cell extract was prepared as described above with
buffer IP (20 mM Tris [pH 7.5], 150 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 0.1%
Triton X-100, 0.1% SDS, and protease and phosphatase inhibitors) and was
precleared with protein A/G-Sepharose 4B resin. Antibody (normally 1 to 5 l of
antibody for 2 ml of extract) was added for 4 to 12 h at 4°C. Two hundred
microliters (50% slurry) of protein A/G resin was added; the resin was incubated
for 2 h at 4°C, collected, and washed three to five times with buffer IP; and the
bound protein was used for Western analysis.
RESULTS
Translational stimulation by the SLBP/stem-loop complex
can be recapitulated in yeast. The 3-terminal stem-loop of
metazoan cell cycle-regulated histone mRNAs to which SLBP
binds is the necessary and sufficient cis-acting element that
directs the efficient translation of this mRNA class (17, 43, 58).
S. cerevisiae lacks a homolog of mammalian SLBP, reflecting
the finding that yeast histone mRNAs are polyadenylated. To
determine whether SLBP is necessary and sufficient to direct
efficient translation, human SLBP was expressed in yeast
(strain INVSc1). Because yeast cannot correctly process a non-
polyadenlyated mRNA terminating in the histone 3 stem-
loop, mRNA terminating in the 3-terminal stem-loop (i.e.,
luc-SLWT [Fig. 1A]) was synthesized in vitro for introduction
by electroporation into yeast. A 32-bp fragment containing the
histone 3 stem-loop was introduced downstream of the lucif-
erase reporter gene (luc) in a T7-based vector (17) from which
capped luc mRNA terminating in the histone stem-loop could
be synthesized in vitro. The stem-loop was positioned 27 bases
downstream of the luc stop codon, similar to the spacing
present in histone mRNAs. As controls, luciferase mRNA
terminating in the histone stem-loop of reverse orientation
(luc-SLR) and a luciferase mRNA containing a 47-nucleotide
3 untranslated region of random sequence (luc-Con) were
included. Following delivery of mRNA (in six replicates) to
yeast in the presence or absence of SLBP expression, luciferase
activity was measured after 3 h of incubation (time sufficient to
allow complete turnover of the introduced mRNA) to deter-
mine the extent of translation from each construct. In yeast
expressing SLBP, translation from luc-SLWT was 19-fold
greater than that from luc-SLR or luc-Con constructs (Fig. 1B,
left panel). In the absence of SLBP, expression from mRNA
terminating in the histone 3 stem-loop was essentially identi-
cal to that from the control mRNAs (Fig. 1B, right panel).
Because the histone stem-loop structure regulates the sta-
bility as well as the translatability of an mRNA in mammalian
cells (17, 34, 41), the physical decay of the introduced lucif-
erase mRNAs in SLBP-expressing and control yeast was ex-
amined. Northern analysis of capped luc-SLWT and luc-SLR
mRNAs introduced into nonsynchronized cells revealed simi-
lar stabilities in yeast in the absence or presence of SLBP (Fig.
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1C), indicating that the increased expression from luc-SLWT in
SLBP-expressing yeast resulted from an increase in its trans-
lation. Because the stability of cell cycle-regulated histone
mRNAs in mammalian cells is controlled by the cell cycle, no
alteration in stability for an mRNA terminating in the histone
stem-loop structure would be expected in nonsynchronized
cells. Determination of the functional mRNA half-life con-
firmed the conclusion drawn from the Northern analysis, in
which each mRNA was translationally active for the same
length of time (Fig. 1D). These results do not preclude the
possibility that the histone stem-loop structure may regulate
mRNA stability in yeast expressing SLBP, but rather, they
demonstrate that the observed increase in expression from luc
mRNA terminating in the histone stem-loop structure in non-
synchronized cells results from increased translatability.
The primary and secondary structure of the metazoan his-
tone stem-loop is highly conserved (Fig. 2). These elements
include a 6-bp stem consisting of two GC base pairs at the base,
a set of three pyrimidine-purine base pairs forming the central
portion of the stem and a UA base pair at the top, and a 4-base
loop in which the first and third positions are uridines and the
fourth position varies. Mutations to the conserved positions of
the loop or stem disrupt its 3-end processing (14, 42) and
translational (17) functions and abolish SLBP binding to the
histone stem-loop in animal cells (61). To investigate whether
the same mutations would be similarly deleterious to the func-
tion of the histone stem-loop in yeast expressing SLBP, the
expression from luciferase mRNAs terminating in mutant
stem-loops (Fig. 2) was examined. Altering the two conserved
uridines in the loop to adenosines (luc-SLA
1,3) abolished stem-
loop function in SLBP-expressing yeast as did inverting either
the entire stem-loop (luc-SLR) or just the stem
(luc-SLReverse stem) (Table 1). Internalization of the stem-loop
(i.e., luc-SLInternal) also resulted in a substantial, although not
complete, loss of function in good agreement with the results
obtained in mammalian cells (17). These data demonstrate
that, as with mammalian cells, the conserved features of the
histone stem-loop that are required for binding SLBP (61) are
required for SLBP-mediated translational regulation in yeast.
To examine whether mutations to SLBP would affect its
translational function, N-terminal- and/or C-terminal-trun-
cated SLBP proteins (58) (Fig. 3A) were expressed in yeast.
The RNA-binding domain was retained in all of the deletions,
and all mutant proteins remained competent for binding RNA
and RNA processing (14, 58). Western analysis using an anti-
His-tagged antibody confirmed that all His-tagged proteins
were expressed to a similar level (Fig. 3A). The translational
regulatory function of the wild-type and mutant SLBP proteins
was determined by measuring the expression from capped luc-
SLWT and luc-SLR mRNAs delivered to yeast expressing each
SLBP construct and calculating the extent to which the histone
stem-loop increased luciferase translation. Deletion of the C-
FIG. 1. SLBP is necessary and sufficient to direct translation from
an mRNA terminating in the histone stem-loop structure. (A) Lucif-
erase (luc) mRNA constructs used in this study: luc-SLWT, which
terminates in the wild-type stem-loop; luc-SLR, in which the 3 stem-
loop is inverted; and luc-Con, which contains a 47-nucleotide random
sequence that is the same length as that of stem-loop-containing con-
structs. (B) Expression from the capped luc mRNAs delivered to
SLBP-expressing yeast (SLBP) and control cells (SLBP). Expres-
sion relative to that from the control mRNA luc-Con (set at a value of
1) for each panel is indicated above each histogram. Each mRNA was
delivered to yeast as six replicates, and the average and standard
deviation are shown. (C) Physical decay of luc-SLWT and luc-SLR
mRNAs following their delivery to SLBP-expressing yeast (SLBP)
and control cells (SLBP) by Northern analysis of total RNA ex-
tracted from an equal number of cells at time points after delivery.
Lane S, in vitro-synthesized luc mRNA. (D) Functional stability of
lucSLWT (F and ) mRNAs following their delivery to control yeast
(E and F) or yeast expressing SLBP ( and ). Translation from the
mRNAs was followed by measurement of luciferase expression at the
time points following mRNA delivery. Once the mRNAs had been
degraded, no further translation could occur and the accumulation of
luciferase ceased, resulting in the observed plateaus.
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terminal 13 amino acids (13C) did not substantially alter
SLBP translational function (Fig. 3B). However, deletion of
the C-terminal 52 amino acids (52C) or the N-terminal 87
amino acids (87N 13C) significantly reduced SLBP transla-
tional function (Fig. 3B). These data indicate that the domains
on each side of the RNA-binding domain are required for
SLBP translational function either for protein interaction or
for correct protein folding. Together, these data demonstrate
that SLBP-mediated translation can be recapitulated in yeast
and that SLBP and the histone stem-loop represent a two-
component regulatory complex that is necessary and sufficient
for this function.
SLBP translational function requires eIF4E, eIF4G, and
eIF3. It has been shown previously that the histone stem-loop
requires the 5 cap for its function during translation (17),
suggesting an interaction between the SLBP/stem-loop com-
plex and the 5 cap or the eIF4F that binds to the 5 cap.
Because an examination of the translation of capped or un-
capped mRNAs in yeast had demonstrated the functional in-
teraction between the 5 cap and poly(A) tail (16, 40, 46), the
expression from capped or uncapped luc-SLWT and luc-SLR
mRNAs was examined in yeast in the presence or absence of
SLBP. In the presence of SLBP, the expression from uncapped
luc-SLWT mRNA was similar to that of luc-SLR mRNA but
was 11-fold greater when the mRNAs were capped (Fig. 4A,
left panel), a degree of stimulation that was not observed in the
absence of SLBP (Fig. 4A, right panel). The data can also be
examined to determine the extent to which the function of the
cap is stimulated by the presence of the histone stem-loop. In
SLBP-expressing yeast, the addition of a cap to luc-SLR
mRNA increased expression 2.0-fold but increased expression
from luc-SLWT 21-fold (Fig. 4A, left panel). These data dem-
onstrate that the 5 cap and histone stem-loop functionally
interact in yeast expressing SLBP and are in good agreement
with previous observations in mammalian cells (17).
To investigate whether SLBP binds to the cap-binding com-
plex, we examined whether SLBP expressed in yeast could be
retained on m7GTP-Sepharose. To determine whether SLBP
binding to m7GTP-Sepharose was eIF4E dependent, SLBP
was expressed in an eIF4Ets mutant strain in which the tem-
perature sensitive (Ts) mutation of eIF4E abolishes its binding
at the nonpermissive temperature of 37°C (1, 3). Expression of
SLBP was readily detected in crude extract from the wild-type
and eIF4Ets mutant strains at 37°C (Fig. 4B). SLBP from
wild-type cells was retained on m7GTP-Sepharose, but that
from eIF4Ets mutant cells failed to bind at 37°C, suggesting
that SLBP binding to m7GTP-Sepharose is eIF4E dependent.
Retention of SLBP on m7GTP-Sepharose was RNA indepen-
FIG. 2. Mutation of conserved positions within the stem-loop disrupts its translational function in yeast. (A) The consensus 3 stem-loop of
histone mRNAs derived from metazoans. Y, pyrimidine; R, purine; N, any nucleotide. The wild-type stem-loop (luc-SLWT) is also shown. In
luc-SLA
1,3, the two conserved uridines in the loop were changed to adenosines; in luc-SLR, the stem-loop was inverted; and in luc-SLReverse stem,
only the stem was inverted. luc-Con served as the negative control. For the luc-SLInternal mRNA, the histone stem-loop was internalized by
restricting the luc-SLWT DNA construct at a PvuII 116 bases downstream of the stem-loop.
TABLE 1. Expression from the luc mRNAs delivered to yeast in
the absence or presence of SLBP
Construct
No SLBP (light
units [105]/mg of
protein)
SLBP (light
units [105]/mg
of protein)
Fold increase
in expression
by SLBPa
luc-SLWT 27.9  1.7 197  6.2 7.1
luc-SLA
1,3 33.1  4.8 36.5  1.0 1.1
luc-SLR 25.2  1.4 17.7  1.1 0.7
luc-SLReverse stem 17.9  2.9 19.2  2.1 1.1
luc-SLInternal 37.5  3.1 60.1  10.8 1.6
luc-Con 18.0  0.6 14.6  0.6 0.8
a The fold increase conferred by the wild-type and mutant structures was
determined as the ratio of luciferase expression in the presence of SLBP to that
in the absence of SLBP.
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dent, as its binding was unaffected by pretreatment of the
extract with RNase A (Fig. 4B).
eIF4E is the small subunit of eIF4F in which eIF4E and
eIF4A are physically associated with the scaffold protein
eIF4G (18, 27, 37). PABP also interacts with eIF4G (55) and
copurifies with eIF4F. To determine whether the presence of
SLBP in the eIF4F complex affects the composition of this
complex, eIF4F was isolated from control and SLBP-express-
ing yeast on m7GTP-Sepharose in the absence of reporter
mRNA. Components of the complex isolated in the absence or
presence of SLBP were visualized by Western analysis (Fig.
4C). SLBP copurified with eIF4F on m7GTP-Sepharose and
did not alter the amount of eIF4G associated with eIF4E.
SLBP copurified with eIF4F even if the extract was pretreated
with RNase (data not shown), suggesting that its interaction
with eIF4F is RNA independent. SLBP was present in a high
ribosomal-salt-wash fraction of yeast ribosomes in the absence
of the stem-loop containing reporter mRNA (Fig. 4D), the
data supporting the conclusion that SLBP copurifies with
eIF4F.
As the association of SLBP with the 5 cap was eIF4E de-
pendent, we used wild-type yeast and strains harboring muta-
tions in key translation initiation factors to investigate the
functional interaction between SLBP and the eIF4F complex.
Null mutants were employed for those factors that are not
essential, e.g., eIF4B or CAF20, whereas Ts mutants or deple-
tion approaches were employed for those factors that have
been shown to have an essential role, including eIF4E, eIF4G,
eIF4A, eIF2, eIF3, and PABP. For the analysis, capped luc-
SLWT and luc-SLR mRNAs were delivered to each mutant in
the absence or presence of SLBP. Since the depletion or loss of
an initiation factor would be expected to reduce translation
nonspecifically, only the loss of the histone stem-loop-medi-
ated increase in luciferase expression would constitute grounds
for concluding that the factor concerned is required for the
SLBP-mediated stimulation of translation.
Because SLBP binding to m7GTP was lost in the eIF4Ets
mutant strain at the nonpermissive temperature (Fig. 4B), we
examined whether the translational function of SLBP required
eIF4E. Expression from luc-SLWT mRNA in the wild-type
eIF4E strain expressing SLBP was 9.2-fold higher than that
from luc-SLR mRNA (Table 2). In agreement with the data
presented in Fig. 1, no enhancement was observed in the ab-
sence of SLBP expression. Similar results were observed at the
FIG. 3. SLBP-mediated translation from the 3 stem-loop requires intact SLBP. (A) His6-tagged SLBP deletion mutants shown were expressed
in yeast, and their expression was determined by Western analysis with an anti-His antibody. FL, full-length SLBP; RBD, RNA-binding domain.
(B) Expression from capped luc-SLWT and luc-SLR mRNAs in yeast expressing wild-type and mutant SLBP is shown. Expression from luc-SLWT
relative to that from luc-SLR (set at a value of 1) for each pair of mRNAs is indicated above each histogram.
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FIG. 4. SLBP requires a functional interaction with the 5 cap and copurifies with eIF4F. (A) Expression from capped and uncapped luc-SLWT
and -luc-SLR mRNAs in yeast in the presence (SLBP) or absence (SLBP) of SLBP is shown. Expression from luc-SLWT relative to that from
luc-SLR (set at a value of 1) for each pair of mRNAs is indicated above each histogram. (B) (Top panel) Extract from wild-type and eIF4E
ts mutant
(strain 4-2) yeast with or without SLBP expression at the nonpermissive temperature (37°C) was bound to m7GTP-Sepharose. The presence of
SLBP in crude extract or in the m7GTP-bound fraction was detected by Western analysis. (Bottom panel) Soluble protein from wild-type CW04 yeast
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nonpermissive temperature (Table 2). Expression from luc-
SLWT mRNA in the eIF4E
ts mutant strain expressing SLBP
was 5.4-fold higher than that from luc-SLR mRNA at the
permissive temperature (Table 2). However, at 37°C, transla-
tion from the luc-SLWT mRNA was preferentially affected,
resulting in a substantial reduction in the SLBP-mediated reg-
ulation (Table 2). As cell growth at 37°C did not influence the
expression of SLBP, these data suggest that SLBP not only
coisolates with eIF4E (Fig. 4) but functionally requires this
factor.
The requirement for nonessential factors involved in the
translation initiation in SLBP-mediated translational enhance-
ment was also examined. CAF20 inhibits eIF4G binding to
eIF4E (2, 10), whereas eIF4B promotes the RNA helicase
function of eIF4A and eIF4F (8). Expression from luc-SLWT
and luc-SLR mRNAs was examined in caf20- or eIF4B-null
strains expressing SLBP (Table 2). In each case, the degree of
SLBP-mediated translational enhancement was similar to that
determined for the wild-type strain CW04 (see below), sug-
gesting that neither factor is specifically required for SLBP
function.
We next investigated whether SLBP functionally requires
eIF4G. eIF4G is expressed from two genes in yeast, and the
proteins (eIF4G1 and eIF4G2) are only 53% homologous (19).
Mutant strains expressing only eIF4G1 (tif4632) or eIF4G2
(tif4631) are viable, but the double null is inviable (19). Be-
cause the depletion of both isoforms of eIF4G can be achieved
by treatment of the yeast with rapamycin (4), we examined the
function of SLBP in wild-type or mutant strains expressing only
eIF4G1 or eIF4G2 before or after rapamycin treatment. Treat-
ment of yeast with rapamycin results in the rapid degradation
of eIF4G without affecting the levels of other eIF4F subunits,
i.e., eIF4E and eIF4A (4). Although rapamycin treatment has
been reported to affect the transcription of some genes in yeast
(45), rapamycin selectively reduces the level of eIF4G through
the destabilization of the existing eIF4G protein (4). We con-
firmed that no degradation of eIF4E (see below) or eIF4A
(data not shown) was observed following rapamycin treatment.
Moreover, rapamycin treatment did not reduce the level of
PABP (see below) or eIF3 (data not shown). Successful deple-
tion of eIF4G following rapamycin treatment was confirmed
(data not shown). Expression from luc-SLWT mRNA in the
wild-type CW04 strain expressing SLBP was 9.2-fold higher
than that from luc-SLR mRNA (Table 3). This SLBP-mediated
enhancement was reduced to control levels in cells treated with
rapamycin (Table 3) despite the fact that no alteration in the
level of SLBP expression was observed (data not shown). The
translational enhancement by SLBP was observed in both the
eIF4G1-deleted and eIF4G2-deleted strains (Table 3), sug-
gesting that either isoform of eIF4G was capable alone of
supporting SLBP function. The lower level of translational
enhancement observed in each mutant was reproducible, pos-
sibly resulting from reduced levels of total eIF4G. As with the
wild-type cells, the translational function of SLBP was virtually
lost in the eIF4G1 or eIF4G2 mutant strains following rapa-
mycin treatment (Table 3), confirming that SLBP function is
dependent on eIF4G.
To determine whether eIF4A is required for SLBP-medi-
ated translational enhancement, expression from luc-SLWT
and luc-SLR mRNAs was measured in an eIF4A
ts mutant
strain which is isogenic with CW04. In strains expressing wild-
type or mutant eIF4A from a multicopy vector, a lower level of
SLBP-mediated enhancement of translation from luc-SLWT
mRNA relative to that from luc-SLR mRNA was observed
even at the permissive temperature (Table 3). However, in
contrast to the findings with eIF4E (Table 2), no reduction in
the SLBP-mediated enhancement of translation was observed
in the eIF4Ats mutant strain at the nonpermissive temperature
(Table 3), suggesting that eIF4A may not be specifically re-
quired for the SLBP-mediated regulation of translation. The
reproducible decrease in SLBP-mediated enhancement ob-
TABLE 2. SLBP translation function requires eIF4E but not caf20 or eIF4B
Temp and factor
No SLBP (light units, 106) SLBP (light units, 106)
SLR SLWT SLWT/SLR SLR SLWT SLWT/SLR
24°C
eIF4E 2.04  0.27 2.38  0.27 1.2 2.71  0.60 25.0  0.96 9.2
eIF4Ets 1.49  0.12 1.91  0.20 1.3 2.26  0.43 12.2  0.85 5.4
37°C
eIF4E 1.97  0.24 2.26  0.33 1.1 1.61  0.23 13.8  0.64 8.6
eIF4Ets 1.15  0.24 1.01  0.15 0.9 1.18  0.15 2.09  0.34 1.8
24°C
caf20 0.26  0.04 0.26  0.05 1.0 0.24  0.04 1.96  0.31 8.2
eIF4B 0.17  0.02 0.16  0.01 0.9 0.16  0.02 2.08  0.29 1.3
expressing SLBP with or without RNase A treatment was bound to m7GTP-Sepharose, and the presence of SLBP in the m7GTP-bound fraction
was detected by Western analysis. (C) Soluble protein from control yeast or yeast expressing SLBP was bound to m7GTP-Sepharose, and the
presence of SLBP, eIF4E, eIF4G, and PABP in the crude extract (Crude), flowed through m7GTP-Sepharose (FT), and in the m7GTP-Sepharose-
bound fraction (m7GTP bound) was determined by Western analysis. (D) Extract from CW04 expressing SLBP was fractionated into the ribosomal
fraction (P100), the supernatant (P100), the ribosomal fraction following the high-salt wash of P100 with 0.5 M NaCl (Ribos), and the ribosomal
salt wash fraction representing ribosomal-bound protein that eluted from P100 with 0.5 M NaCl (RSW). The presence of SLBP in the crude extract
and each fraction was detected by Western analysis.
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served in strains expressing wild-type and mutant eIF4A may
be a consequence of their expression from a multicopy vector.
eIF4G functions to recruit eIF3, which in turn is responsible
for promoting binding of the 40S ribosomal subunit to an
mRNA (31). To determine whether SLBP requires eIF3, a
mutant strain containing a Ts mutation in the Prt1 (eIF3b)
subunit (22, 39) was employed. Expression from luc-SLWT
mRNA in the wild-type eIF3 strain expressing SLBP was 9.1-
fold higher than that from luc-SLR mRNA, which was altered
little when the cells were shifted to 37°C (Table 4). SLBP-
mediated translational enhancement was reproducibly lower in
the prt1-1 mutant strain at the permissive temperature and was
abolished when the cells were shifted to 37°C (Table 4) despite
the fact that no alteration in the level of SLBP expression was
observed, the data suggesting that SLBP function is dependent
on eIF3.
Translation initiation is also controlled at the level of initi-
ator tRNA binding to the 40S ribosomal subunit, mediated by
the physiological regulation of eIF2 activity (27, 28, 29). For
example, increased phosphorylation of the  subunit of eIF2
(eIF2) at serine 51 by GCN2 in response to amino acid
starvation reduces eIF2 activity in S. cerevisiae (28, 29). Muta-
tion of Ser-51 to alanine (eIF2-S51A) prevents phosphoryla-
tion and results in constitutive activity, whereas mutation of the
serine to aspartic acid (eIF2-S51D) mimics phosphorylation
and results in constitutively reduced activity (11). To examine
whether changes in eIF2 function affect SLBP function, ex-
pression from luc-SLWT and luc-SLR mRNAs was measured in
the absence or presence of SLBP in wild-type, GCN2 mutant
yeast and strains expressing eIF2 containing either the S51A
or S51D mutations (Table 5). SLBP function in these strains
was examined in cells not experiencing amino acid starvation
(i.e., for histidine) and following starvation for histidine, which
induces GCN2 activity. SLBP was expressed to a similar level
in all strains (data not shown). In nonstarved cells, translation
from luc-SLWT mRNA in wild-type eIF2/GCN2 cells express-
ing SLBP was 13-fold higher than that from luc-SLR mRNA
(Table 5). No reduction in the degree of SLBP-mediated en-
hancement of translation was observed in eIF2-S51A/GCN2
or eIF2/gcn2 cells (Table 5). Furthermore, in eIF2-S51D/
GCN2 cells, the degree of SLBP-mediated enhancement was
not reduced (Table 5). In starved cells, the SLBP-mediated
enhancement of translation was abolished in eIF2/GCN2
cells as well as in eIF2-S51A/GCN2 and eIF2-S51D/GCN2
cells. A similar loss in SLBP function was observed in station-
ary-phase cells (data not shown). Partial retention of SLBP
activity was observed in eIF2/gcn2 cells, possibly indicating
that eIF2 may be partially functionally required for SLBP or
that the loss of GCN2 function may lead to changes in other
components of the translational machinery that are involved in
the activity of SLBP. These data suggest that amino acid star-
vation results in changes in the translation machinery that
result in the loss of SLBP-mediated regulation and are partially
TABLE 3. SLBP translation function requires eIF4G
Condition and factor
or strain
No SLBP (light units 106) SLBP (light units 106)
SLR SLWT SLWT/SLR SLR SLWT SLWT/SLR
No rapamycin
CW04 1.32  0.08 1.39  0.26 1.1 1.59  0.29 14.7  0.63 9.2
tif4631 1.24  0.20 0.96  0.11 0.8 0.96  0.13 7.53  0.33 7.8
tif4632 1.03  0.16 1.02  0.19 1.0 1.32  0.12 5.54  0.19 4.2
With rapamycin
CW04 2.02  0.40 2.21  0.48 1.1 1.56  0.19 3.47  0.14 2.2
tif4631 0.70  0.08 0.81  0.22 1.2 0.37  0.11 0.62  0.37 1.7
tif4632 0.27  0.18 0.39  0.17 1.4 0.43  0.17 0.67  0.29 1.6
24°C
eIF4Ats 1.19  0.42 1.23  0.19 1.0 0.97  0.13 3.28  0.66 3.4
eIF4AWT 1.89  0.35 1.70  0.45 0.9 1.79  0.10 5.89  0.92 3.3
37°C
eIF4Ats 0.58  0.08 1.12  0.09 1.9 0.83  0.10 3.30  0.28 4.0
eIF4AWT 1.48  0.26 2.19  0.59 1.5 1.37  0.37 7.50  0.84 5.4
TABLE 4. SLBP translation function requires eIF3
Temp and factor
No SLBP (light units, 106) SLBP (light units, 106)
SLR SLWT SLWT/SLR SLR SLWT SLWT/SLR
24°C
eIF3b 0.94  0.11 1.17  0.09 1.2 1.01  0.18 9.18  0.29 9.1
eIF3bts 0.73  0.08 0.87  0.08 1.2 0.70  0.20 3.76  0.36 5.4
37°C
eIF3b 0.65  0.06 0.76  0.05 1.2 0.54  0.04 4.71  0.28 8.7
eIF3bts 0.39  0.05 0.34  0.06 0.9 0.28  0.03 0.38  0.04 1.4
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controlled by GCN2 but may not involve changes in eIF2
phosphorylation.
PABP interacts with eIF4G and functions to promote 48S
complex formation (48, 54). Although cell cycle-regulated hi-
stone mRNAs do not contain a poly(A) tail, SLBP may still
interact with and require PABP. To determine whether SLBP
functionally requires PABP, expression from luc-SLWT and
luc-SLR mRNAs was measured in a mutant strain expressing
PABP under the control of a galactose-inducible (Gal1) pro-
moter (49). Yeast were grown in galactose-containing medium
and switched to glucose for 20 h to deplete PABP in the cells,
which was confirmed by Western blotting of both the crude
extracts (Fig. 5A, first two lanes) and of poly(A)-agarose
bound fractions (Fig. 5A, last two lanes). In yeast grown in the
presence of galactose, SLBP was recovered on poly(A)-aga-
rose in association with PABP in the absence of added mRNA.
Expression from luc-SLWT mRNA in yeast expressing SLBP
and grown in galactose-containing medium was 4.5-fold higher
than that from luc-SLR mRNA (Fig. 5B) and was altered little
following the depletion of PABP, suggesting that SLBP does
not require PABP. Despite the fact that a substantial decrease
in the level of PABP had no effect on SLBP-mediated regula-
tion, we cannot rule out the possibility that PABP may be
required if the small amount of PABP remaining after the
depletion is sufficient to fulfill its role in this mechanism.
To further investigate SLBP coisolation with PABP, PABP
from yeast expressing SLBP was allowed to bind to poly(A)-
agarose. To eliminate the possibility of any RNA tethering
between SLBP and PABP, the extract was treated with RNase
A, which was inactivated with DTT (data not shown) prior to
loading onto poly(A)-agarose. As shown in Fig. 5C, SLBP was
present in the poly(A)-bound fraction whether or not the ex-
tract was pretreated with RNase A but did not bind poly(A)-
agarose in the absence of PABP (Fig. 5A). These data suggest
that, although SLBP can coisolate in a complex containing
PABP, the latter is not required for the SLBP-mediated en-
hancement of translation with reporter mRNAs.
Interaction of SLBP with eIF4F requires eIF4G and eIF3
but not eIF4E or eIF4A. As the genetic analysis in yeast re-
vealed a functional requirement for eIF4E, eIF4G, and eIF3
for the SLBP-mediated regulation of translation and SLBP can
be retained on m7GTP-Sepharose (Fig. 4), these data suggest
that SLBP may physically interact with one or more of these
proteins. Such an interaction may promote a physical interac-
tion between the termini of histone mRNAs, functionally cir-
cularizing the mRNA and facilitating its translation. The re-
quirements for the interaction of SLBP with eIF4F were
further investigated by examining the binding of SLBP to
m7GTP-Sepharose when SLBP was expressed in the same
strains described above (eIF4G2 [tif4631], eIF4G1 [tif4632],
eIF4Ets, eIF4Ats, or prt1-1). In addition, the requirement for
eIF4G was investigated by examining whether SLBP from con-
trol or rapamycin-treated tif4631 and tif4632 cells was retained
on m7GTP-Sepharose. As observed in Fig. 4, SLBP was re-
tained on m7GTP-Sepharose from extract prepared from
tif4631 and tif4632 mutants (Fig. 6). However, retention of
SLBP on m7GTP-Sepharose was lost when either mutant was
treated with rapamycin (Fig. 6). The effect of rapamycin treat-
ment on reducing the level of eIF4G appeared to be selective,
as the treatment had no effect on the level of eIF4E in crude
extract (Fig. 6), as has been reported previously (4) as well as
on eIF4A, eIF3 (see above), and PABP (see below), suggesting
that the reduction in the coisolation of SLBP was not a result
of a decrease in eIF4E or these other factors. The observation
that SLBP was retained on m7GTP-Sepharose in tif4631 or
tif4632 mutants prior to but not following their treatment with
rapamycin suggests that the association of SLBP with eIF4F
requires eIF4G. Retention of SLBP on m7GTP-Sepharose was
observed in the eIF4Ets mutant at the permissive temperature
but not at the nonpermissive temperature (Fig. 6), confirming
the requirement for eIF4E in mediating the binding of SLBP
to m7GTP-Sepharose, observed in Fig. 4. In contrast, the re-
tention of SLBP on m7GTP-Sepharose when expressed in the
eIF4Ats mutant was similar at the permissive and nonpermis-
sive temperatures (Fig. 6), suggesting that eIF4A is not re-
quired for SLBP to copurify with eIF4F. Retention of SLBP on
m7GTP-Sepharose was unaffected in the prt1-1 (eIF3bts) mu-
tant strain at the permissive temperature but not at 37°C (Fig.
6), indicating that active eIF3 is at least partially required for
SLBP to copurify with eIF4F.
We also examined whether the coisolation of SLBP with
PABP observed in Fig. 5C was dependent on eIF4E, eIF4G, or
eIF3. To this end, extracts from the same strains expressing
SLBP were loaded onto poly(A)-agarose resin and the reten-
tion of SLBP was determined by Western analysis. Figure 7
shows that, while SLBP was recovered with PABP in untreated
tif4631 or tif4632 mutants cells, its coisolation with PABP was
substantially reduced following rapamycin treatment, particu-
TABLE 5. eIF2 is not specifically required for SLBP translation function
Condition and cell type
No SLBP (light units, 106) SLBP (light units, 106)
SLR SLWT SLWT/SLR SLR SLWT SLWT/SLR
Nonstarved
eIF2/GCN2 0.17  0.04 0.20  0.04 1.2 0.13  0.03 1.67  0.58 13
eIF2/gcn2 0.29  0.05 0.31  0.07 1.1 0.10  0.06 1.79  0.72 18
eIF2-S51A/GCN2 0.12  0.03 0.15  0.04 1.3 0.07  0.04 1.53  0.56 22
eIF2-S51D/GCN2 0.19  0.03 0.25  0.02 1.3 0.07  0.02 1.19  0.61 17
Starved
eIF2/GCN2 0.48  0.09 0.68  0.07 1.4 0.80  0.17 0.90  0.60 1.1
eIF2/gcn2 0.26  0.05 0.22  0.02 0.8 0.72  0.17 2.54  0.60 3.5
eIF2-S51A/GCN2 1.45  0.30 1.48  0.10 1.0 0.97  0.12 1.14  0.28 1.2
eIF2-S51D/GCN2 1.37  0.25 0.88  0.38 0.6 2.34  0.15 3.02  0.99 1.3
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larly in the tif4631 mutant. Rapamycin treatment had little to
no effect on the level of PABP and had no effect on the amount
of PABP recovered on poly(A)-agarose resin (Fig. 7), suggest-
ing that the reduction in the coisolation of SLBP in rapamycin-
treated cells was not a result of a decrease in PABP (or eIF4E,
eIF4A, or eIF3). Moreover, once normalized to the level of
PABP in untreated crude extract, the level of SLBP in extract
from rapamycin-treated cells was not substantially different
from that from nontreated cells. These data suggest that
eIF4G was required for the coisolation of SLBP with PABP.
Retention of SLBP on poly(A)-agarose resin was not depen-
FIG. 5. SLBP copurifies with PABP on poly(A)-agarose.
(A) Yeast, in which expression of PABP is under the control of the
galactose-inducible promoter (pGAL-PABP), was grown in galactose
and switched to either galactose- or glucose-containing medium and
grown for a further 20 h. Soluble protein from an equal number of cells
was bound to poly(A)-agarose. The presence of SLBP or PABP in
crude extract (Crude) or in the poly(A)-bound fraction was deter-
mined by Western analysis. (B) Luciferase expression from capped
luc-SLWT and luc-SLR mRNAs was examined in the galactose- or
glucose-grown yeast shown to the left. Expression from luc-SLWT rel-
ative to that from luc-SLR (set at a value of 1) for each pair of mRNAs
is indicated above each histogram. (C) Extract from yeast expressing
SLBP treated with or without RNase A was bound to poly(A)-agarose,
and SLBP and PABP were detected by Western analysis.
FIG. 6. eIF4G and eIF3 are required for SLBP copurification with
eIF4E. Soluble protein from each indicated yeast strain expressing
SLBP was bound to m7GTP-Sepharose. The presence of SLBP and
eIF4E in crude extract (Crude) or in the m7GTP-bound fraction was
determined by Western analysis. Rapamycin (Rapa) treatment of
tif4631 and tif4632 mutants to deplete eIF4G or treatment at 37°C of
the eIF4Ats, prt1-1, and eIF4Ets mutant strains is as indicated. HS, heat
stress at the nonpermissive temperature.
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dent on eIF4E or eIF4A but did require eIF3 (Fig. 7). These
data suggest that SLBP does not interact directly with PABP or
eIF4E, but rather, it associates with the eIF4F/PABP complex
via its association with eIF4G and, in part, with eIF3. Despite
detecting no decrease in eIF4E, PABP, eIF4A, or eIF3 in
rapamycin-treated cells, it is formally possible that a reduction
in a protein not examined may also be involved in the coiso-
lation of SLBP in this assay.
Purification of His6-tagged SLBP was also used to investi-
gate its in vivo interactions. As shown in Fig. 8A, His6-tagged
SLBP was as active as the untagged protein in promoting
translation from luc-SLWT mRNA relative to that from luc-
SLR mRNA. eIF4G, eIF4A, Nip1, and Pab1p specifically co-
purified with His6-tagged SLBP in the absence of the histone
stem-loop (Fig. 8B, last lane versus middle lane), while eIF4E
was retained nonspecifically by the resin in the absence of
SLBP (Fig. 8B, middle lane). Furthermore, eIF4G1 and
eIF4G2 each copurified with His6-tagged SLBP (Fig. 8C), sug-
gesting that SLBP can assemble with either isoform of eIF4G,
correlating with the ability of each eIF4G mutant strain to
support SLBP translational function (Table 3). These data
support the conclusion that SLBP assembles into a cap-binding
complex via eIF4G.
SLBP associates with eIF4G in mammalian cells. To exam-
ine whether SLBP assembles with eIF4G in mammalian cells,
immunoprecipitation of endogenous SLBP from 293 cells was
performed with an antibody raised against the SLBP C-termi-
nal 13-amino acid peptide (Fig. 9A, middle lane), with recovery
blocked by the corresponding competing peptide (Fig. 9A, last
lane versus middle lane). eIF4G specifically coimmunoprecipi-
tated with SLBP (Fig. 9B, middle lane), supporting the obser-
vations from yeast that SLBP assembles into a complex with
eIF4G. eIF3 was not detected in these immunoprecipitates
(data not shown), suggesting that the interaction between
SLBP and eIF4G may be direct and stable. In a reciprocal
experiment, SLBP was observed to coimmunoprecipitate with
eIF4G (Fig. 9C). The use of anti-eIF3 serum resulted in the
coimmunoprecipitation of SLBP but to a level that was signif-
icantly lower than that obtained with anti-eIF4G serum (Fig.
9C). The recovery of SLBP in the immunoprecipitate corre-
lated more closely with that of eIF4G rather than that of eIF3,
suggesting that eIF4G may be more important for the assembly
of SLBP with eIF4F.
We next examined whether recombinant SLBP could inter-
act with recombinant eIF4G. Recombinant SLBP was added to
binding reaction mixtures containing recombinant human
eIF4E (expressed in and purified from Escherichia coli) and/or
recombinant human eIF4G (expressed in insect cells). Inter-
action of SLBP with either initiation factor was determined by
Western analysis of the protein retained on m7GTP-Sepharose
resin. SLBP was not retained on the resin in the absence or
presence of eIF4E (Fig. 9D, lanes 1 and 2). A high level of
SLBP was retained only when recombinant eIF4E and extract
from insect cells expressing human eIF4G were added (Fig.
9D, lane 5), suggesting that eIF4G was required for SLBP to
bind the resin. A low level of SLBP was retained in the absence
or presence of eIF4E when control insect extract was added
(Fig. 9D, lanes 3 and 4), suggesting that insect eIF4G can also
interact with SLBP.
Together, the data from yeast and mammalian cells suggest
that the physical interaction of SLBP with eIF4F requires
eIF4G, and perhaps eIF3, but does not require eIF4E, eIF4A,
or PABP.
FIG. 7. eIF4G and eIF3 are required for SLBP copurification with
PABP. Soluble protein from each indicated yeast strain expressing
SLBP was bound to poly(A)-agarose. The presence of SLBP and
PABP in crude extract (Crude) or in the poly(A)-bound fraction was
determined by Western analysis. Rapamycin treatment of tif4631 and
tif4632 mutants to deplete eIF4G or treatment at 37°C of the eIF4Ats,
prt1-1, and eIF4Ets mutant strains is as indicated. HS, heat stress at the
nonpermissive temperature.
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DISCUSSION
The cell cycle-regulated histone mRNAs are unique in that
they terminate in a highly conserved stem-loop that is bound by
SLBP. Although the 3-terminal stem-loop serves as the func-
tional equivalent to a poly(A) tail in that it functionally inter-
acts with the 5 cap to enhance translation (17), there was no
information on whether SLBP was necessary and sufficient to
mediate this function. Because S. cerevisiae lacks a homolog to
SLBP and yeast histone mRNAs are polyadenylated, this spe-
cies could be used to examine the requirements for the histone
stem-loop-mediated regulation. We found that histone stem-
loop-mediated regulation could be recapitulated in yeast, with
expression of SLBP necessary and sufficient to mediate the
translation regulation associated with the histone stem-loop
(Fig. 1). The stem-loop was functionally dependent on the
presence of a cap structure at the 5 terminus of the mRNA
(Fig. 4A), a finding previously described for mammalian cells
(17). Moreover, mutations to the conserved features of the
stem-loop structure were deleterious to its translational func-
tion in yeast (Table 1) and mammalian cells (17). Additionally,
deletion of the N-terminal or C-terminal domains, which alone
do not affect SLBP binding to the histone stem-loop, reduced
the ability of the protein to stimulate translation (Fig. 3). The
ability of SLBP to function in the context of the yeast cellular
environment suggests that at least some of its molecular inter-
actions with the yeast translational machinery are similar to
those of animals.
The observations presented in this study suggest that SLBP
functionally and physically interacts with eIF4G and eIF3. This
conclusion is supported by multiple independent lines of evi-
dence. First, the function of SLBP in yeast was genetically
dependent on eIF4G and eIF3 (Tables 3 and 4). Second, co-
purification of SLBP with the eIF4F/eIF3/PABP complex was
observed when the latter was purified by m7GTP-Sepharose or
poly(A)-agarose chromatography (Fig. 4C, 6, and 7). Third,
eIF4G and eIF3 were required for the association of SLBP
with the eIF4F/eIF3/PABP complex (Fig. 7). Fourth, copurifi-
cation of eIF4G and eIF3 with SLBP was observed when the
latter was affinity purified as a His-tagged protein (Fig. 8).
Fifth, mammalian eIF4G coimmunoprecipitated with SLBP
(Fig. 9B). Sixth, SLBP coimmunoprecipitated with eIF4G or
with eIF3 from mammalian cells (Fig. 9C). Seventh, an inter-
action between recombinant mammalian eIF4G and SLBP was
observed (Fig. 9D). The observation that recombinant human
SLBP and eIF4G interact in vitro suggests that the interaction
may be direct.
In addition to eIF4G and eIF3, eIF4E was necessary for
SLBP translational function (Table 2). This finding is consis-
tent with the observation that the translational enhancement
conferred by the histone stem-loop structure is cap dependent
(17) and that the translational function of SLBP requires a 5
FIG. 8. eIF4G copurifies with SLBP from yeast. (A) Luciferase
expression from capped luc-SLWT and luc-SLR mRNAs was examined
in control yeast or yeast expressing wild-type or N-terminal His6-
tagged SLBP. Expression from luc-SLWT relative to that from luc-SLR
(set at a value of 1) for each pair of mRNAs is indicated above each
histogram. (B) His6-tagged SLBP was isolated by Co
2-affinity chro-
matography (last lane). Yeast containing the empty His6-tagged vector
was used as a control (middle lane). The presence of SLBP, eIF4G,
eIF4A, eIF4E, the Nip1 subunit of eIF3, and Pap1p in crude extract
(lane 1) or in the Co2-bound fractions was determined by Western
analysis with factor-specific antibodies. (C) His6-tagged SLBP was iso-
lated from CW04 and tif4631 and tif4632 mutants by Co2-affinity
chromatography. Yeast containing the empty His6-tagged vector (sec-
ond lane) was used as a control. The presence of eIF4G and SLBP was
determined by Western analysis.
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cap (Fig. 4A). Because no direct physical interaction between
SLBP and eIF4E was observed (Fig. 9D), eIF4E likely con-
tributes to SLBP function by facilitating the binding of eIF4F
to the 5 cap, which may be necessary for the interaction
between SLBP and eIF4G in a manner analogous to the role of
eIF4E in facilitating the interaction between eIF4G and PABP
during the translation of capped and polyadenylated mRNAs
(56, 60). Therefore, a model incorporating the present obser-
vations posits that the functional interaction of the 5 cap with
the 3 histone stem-loop structure involves an interaction of
the cap-bound eIF4E with eIF4G, which in turn interacts with
the SLBP-bound 3-terminal histone stem-loop structure (Fig.
10). The presence of other initiation factors, including eIF2
(which may be partially required for SLBP function) and eIF1,
e1F1A, and eIF5, would be expected as part of the initiation
complex.
FIG. 9. SLBP and eIF4G copurify from mammalian cells. (A) SLBP was subject to immunoprecipitation (IP) from 293 cells with anti-SLBP
antibody in the absence (-SLBP) or presence (-SLBP  SLBP peptide) of the SLBP 13-amino-acid C-terminal peptide used for production of
the anti-SLBP antiserum and detected by Western analysis. (B) Immunoprecipitation from 293 cells was performed with preimmune antiserum
(Pre-Im) or anti-SLBP antiserum (-SLBP) in the absence or presence of the 13-amino-acid C-terminal SLBP peptide. eIF4G was detected by
Western analysis. The antibody (Ab) used for the immunoprecipitation is indicated. A nonspecific band is also present in all lanes. (C) eIF4G or
eIF3 was immunoprecipitated from 293 cells with anti-eIF4G or anti-eIF3 antiserum, respectively, and eIF4G, eIF3, and SLBP were detected by
Western analysis. Preimmune antiserum for each was also used. A nonspecific band detected during SLBP Western analysis was also present.
(D) Recombinant SLBP was added to binding reaction mixtures containing recombinant human eIF4E (expressed in and purified from E. coli)
and/or recombinant human eIF4G (expressed in insect cells) as indicated. eIF4E, eIF4G, and SLBP loaded onto m7GTP-Sepharose resin and that
retained on the resin was detected by Western analysis. The faint eIF4E and eIF4G signals in lane 3 represent the insect homologs.
FIG. 10. Proposed physical and function model of the association
of SLBP with the eIF4F/eIF3/PABP complex. SLBP is shown bound to
the 3-terminal stem-loop of a cell cycle-regulated histone mRNA.
Association of SLBP with the eIF4F/eIF3/PABP complex requires
eIF4G and perhaps eIF3. eIF4E is not required for the physical asso-
ciation of SLBP with the complex but is required for SLBP function in
that it is necessary for the binding of the complex to the 5 cap. Other
initiation factors including eIF2 (which may be partially required),
eIF5, eIF1, and eIF1A are not shown for simplicity but would be
expected to be present.
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Although yeast express two eIF4G proteins that are only
53% homologous (19), SLBP function was maintained as long
as at least one eIF4G protein was expressed. Moreover,
eIF4G1 or eIF4G2 were each found to copurify with SLBP
when the latter was isolated from yeast strains solely expressing
eIF4G1 or eIF4G2, confirming that SLBP can assemble with
either eIF4G. The observed coimmunoprecipitation of eIF4G
with SLBP and SLBP with eIF4G from mammalian cell extract
as well as the interaction between recombinant mammalian
SLBP and mammalian eIF4G (Fig. 9) supports the conclusion
that the coassembly of SLBP and eIF4G in yeast may be
representative of what occurs in mammalian cells. Further
work will be needed to determine whether SLBP exhibits a
functional preference for eIF4GI or eIF4GII (20) in mamma-
lian cells.
Our results suggest that, from the perspective of transla-
tional regulation, SLBP has evolved as a functional mimic of
PABP in that it binds to a 3-terminal sequence, exhibits a
functional requirement for the 5 cap, copurifies with the
eIF4F complex, and requires eIF4G to mediate its association
with the complex. However, SLBP is distinct from PABP in
that it may involve an interaction with eIF3 and regulates
histone mRNA stability in a cell cycle fashion. Further inves-
tigation into the functional and physical parallels between
SLBP and PABP in their interaction with the translational
initiation machinery will provide valuable insight into the evo-
lution of diverse molecular mechanisms that promote efficient
translation.
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